Peptide YY3-36(Gila Therapeutics)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePeptide YY3-36(Gila Therapeutics)
Drug Alias NamePeptide-YY3-36Peptide-YY (3-36)GT-001-Gila TherapeuticsPYY(3-36)PYY3-36-Gila Therapeutics +[6] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuropeptide Y receptors agonists
TargetsNeuropeptide Y receptors
Therapy Area/IndicationsFeeding and Eating DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGila Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncGila Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersObesity

Other Information

ATC CodeN/A
Related LinksN/A